Goldenrod Therapeutics
Last verified 2026-06-17. JSON
| Total raised | $3.2M |
|---|---|
| Latest round | Funding round, $3.2M, 2026-06-03 |
| Founded | unknown |
| Headquarters | Houston, Texas |
| Industry | biotechnology |
| Stage | unknown |
| Website | goldenrodtherapeutics.com |
Next-generation PDE4 inhibitor for neurological conditions
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-06-03 | Funding round | $3.2M | undisclosed |
Detected tech stack
@sentry/browser, adobe fonts, afterpay, hsts, moment 0, sentry, squarespace, squarespace commerce, stimulus, typekit
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $3.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $3.2M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | goldenrodtherapeutics.com, read 2026-06-17 |
| Description | self-reported | goldenrodtherapeutics.com, read 2026-06-17 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $3.2M, 2026-06-03 → Funding round, $3.2M, 2026-06-03, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $3.2M, 2026-06-03 → Funding round, $3.2M, 2026-06-03 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes